Need Access?
If you are a licensed provider and would like to access the Practitioner List, or your payment statements please e-mail nlpdp@bell.ca to request a USERNAME and PASSWORD.

 
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit list update: new addition to an existing category: Kesimpta 1672022-Nov-28Word PDF
Benefit list update: new addition to an existing category: Xolair 150mg/ml prefilled syringe1662022-Nov-28Word PDF
NLPDP Benefit Status Effective December 1, 20221652022-Nov-24Word PDF
NIDPF Vol. 87 Supplement Effective December 1, 2022 - Refer to Bulletin #165 for Benefit Status1642022-Nov-24Word PDF
Updates under the Smoking Cessation Program1632022-Nov-22Word PDF
Update - Short-Stock: Dorzolamide 20mg/ml1622022-Nov-21Word PDF
Benefit List Update: New additions Crysvita1612022-Nov-21Word PDF
Benefit List Update: Ethinyl Estradiol/Cyproterone 35mcg/2mg Tablets1602022-Nov-18Word PDF
Benefit list updates_New Additions to Existing Category_GALANTAMINE and RIVASTIGMINE1592022-Nov-14Word PDF
Short-Stock: Dorzolamide 20mg/ml1582022-Nov-09Word PDF
Short-Stock: Cefixime 100mg/5ml1572022-Nov-09Word PDF
Update - Short-Stock: Methylphenidate HCL 54 mg1562022-Nov-04Word PDF
Benefit List Updates_New Addition_Calquence 100mg1552022-Nov-03Word PDF
Online version of NIDPF Vol. 87 effective November 1, 20221542022-Nov-01Word PDF
Reimbursement of COVID-19 Vaccinations under the (NLPDP) Addition of Pfizer Bivalent Vaccine1532022-Oct-21Word PDF
Update - Short-Stock: Methylphenidate HCL 36 mg1522022-Oct-21Word PDF
Update - Short-Stock: Methylphenidate HCL 18 mg1512022-Oct-21Word PDF
Update - Short-Stock: Methylphenidate HCL 27 mg1502022-Oct-21Word PDF
Benefit List Update - Open Benefit Donepezil 5mg and 10mg1492022-Oct-20Word PDF
Benefit List Update: New additions to an existing category Skyrizi 150mg/ml1482022-Oct-20Word PDF
Page  Go
Page 1 of 51
Document Name: Date Range: To


Document NameDateView
Coverage Status Table - November 20222022-Nov-15 PDF
Coverage Status Table - October 20222022-Oct-11 PDF
Coverage Status Table - September 20222022-Sep-14 PDF
Coverage Status Table - August 20222022-Aug-25 PDF
Coverage Status Table - July 20222022-Jul-19 PDF
Coverage Status Table - June 2022 2022-Jun-28 PDF
Coverage Status Table - May 2022 2022-May-13 PDF
Coverage Status Table - April 20222022-Apr-27 PDF
Coverage Status Table - March 20222022-Mar-25 PDF
Coverage Status Table - February 20222022-Feb-18 PDF
Coverage Status Table - January 20222022-Jan-25 PDF
Coverage Status Table - December 20212021-Dec-10 PDF
Coverage Status Table - November 20212021-Nov-05 PDF
Coverage Status Table - September 20212021-Sep-02 PDF
Coverage Status Table - July 20212021-Jul-22 PDF
Coverage Status Table - June 20212021-Jun-24 PDF
Coverage Status Table - May 20212021-May-19 PDF
Coverage Status Table - April 20212021-Apr-23 PDF
Coverage Status Table - March 20212021-Mar-22 PDF
Coverage Status Table - February 20212021-Feb-11 PDF
Page  Go
Page 1 of 2
Document Name: Date Range: To


Document NameDateView
Diabetic Listing - June 15, 2022 (Refer to Bulletin #82 posted on June 15, 2022)2022-Jun-15Word PDF
Diabetic Listing - March 18, 2022 (Refer to Bulletin #39 posted on March 18, 2022)2022-Mar-21Word PDF
Diabetic Listing - March 2, 2022 (Refer to Bulletin #35 posted on March 2, 2022)2022-Mar-02Word PDF
Diabetic Listing - January 13, 2022 (Refer to Bulletin #4 posted on January 13, 2022)2022-Jan-13Word PDF
Diabetic Listing - January 10, 2022 (Refer to Bulletin #2 posted on January 10, 2022)2022-Jan-10Word PDF
Diabetic Listing - January 12, 2021 (Refer to Bulletin #9 posted on January 12, 2021)2021-Jan-12Word PDF
 
Page 1 of 1
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit list update: new addition to an existing category: Kesimpta 1672022-Nov-28Word PDF
Benefit list update: new addition to an existing category: Xolair 150mg/ml prefilled syringe1662022-Nov-28Word PDF
Benefit List Update: New additions Crysvita1612022-Nov-21Word PDF
Benefit List Update: Ethinyl Estradiol/Cyproterone 35mcg/2mg Tablets1602022-Nov-18Word PDF
Benefit list updates_New Additions to Existing Category_GALANTAMINE and RIVASTIGMINE1592022-Nov-14Word PDF
Benefit List Updates_New Addition_Calquence 100mg1552022-Nov-03Word PDF
Benefit List Update - Open Benefit Donepezil 5mg and 10mg1492022-Oct-20Word PDF
Benefit List Update: New additions to an existing category Skyrizi 150mg/ml1482022-Oct-20Word PDF
Benefit List Update_Criteria Update_LURASIDONE1452022-Oct-20Word PDF
Benefit list updates_New addition_ALUNBRIG 30mg, 90mg, 180mg, and Starter Kit1442022-Oct-19Word PDF
Benefit List Update_Criteria Update: RITUXIMAB1402022-Oct-12Word PDF
Benefit List Update_New Critieria_Venclexta 10mg, 50mg, 100mg1392022-Oct-11Word PDF
New Addition_TRURAPI 1342022-Sep-29Word PDF
Benefit List Update: New Addition: Kynmobi sublingual film1192022-Aug-19Word PDF
Benefit List Update: Open Benefit: Depo-Provera 1182022-Aug-18Word PDF
Benefit List Update: New Addition to an existing category: TRIKAFTA 50MG/25MG/37.5MG/75MG TABLET1152022-Aug-08Word PDF
Benefit Status Update: Special Authorization: Topical Testosterone Criteria Change 1092022-Jul-28Word PDF
Benefit List Update: New Addition: ILUMYA 100MG/ML Subcutaneous pre-filled syringe1082022-Jul-25Word PDF
Benefit List Update: New Addition: Vocabria and Cabenuva1032022-Jul-20Word PDF
Benefit list update: New Addition: DUOBRII 0.01 Percent - 0.045 Percent Lotion982022-Jul-07Word PDF
Page  Go
Page 1 of 7
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Update - Short-Stock: Dorzolamide 20mg/ml1622022-Nov-21Word PDF
Short-Stock: Dorzolamide 20mg/ml1582022-Nov-09Word PDF
Short-Stock: Cefixime 100mg/5ml1572022-Nov-09Word PDF
Update - Short-Stock: Methylphenidate HCL 54 mg1562022-Nov-04Word PDF
Update - Short-Stock: Methylphenidate HCL 36 mg1522022-Oct-21Word PDF
Update - Short-Stock: Methylphenidate HCL 18 mg1512022-Oct-21Word PDF
Update - Short-Stock: Methylphenidate HCL 27 mg1502022-Oct-21Word PDF
Update - Short-Stock: Bupropion 150mg1432022-Oct-17Word PDF
Short-Stock: Methylphenidate HCL 27 mg1422022-Oct-14Word PDF
Update - Short-Stock: Dabigatran 110mg1382022-Oct-07Word PDF
Update - Short-Stock: Dabigatran 150mg1372022-Oct-07Word PDF
Short-Stock: Octreotide 20mg/Vial1362022-Oct-05Word PDF
Update - Short-Stock: Bupropion 300mg1352022-Oct-03Word PDF
Short-Stock: Methylphenidate HCL 54 mg1322022-Sep-27Word PDF
Short-Stock: Tobramycin 60mg/ml1312022-Sep-26Word PDF
Short-Stock: Bupropion 150mg1262022-Sep-07Word PDF
Update: Short-Stock: Brimonidine Tartrate . 0.2 percent1232022-Aug-26Word PDF
Short-Stock: Bupropion 300mg1202022-Aug-23Word PDF
Short-Stock: Methylphenidate HCL 36 mg1172022-Aug-15Word PDF
Short-Stock: Brimonidine Tartrate 0.2 Percent1132022-Aug-01Word PDF
Page  Go
Page 1 of 5
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
NLPDP Benefit Status Effective December 1, 20221652022-Nov-24Word PDF
NIDPF Vol. 87 Supplement Effective December 1, 2022 - Refer to Bulletin #165 for Benefit Status1642022-Nov-24Word PDF
Online version of NIDPF Vol. 87 effective November 1, 20221542022-Nov-01Word PDF
NLPDP Benefit Status Effective November 1, 20221472022-Oct-20Word PDF
NIDPF Vol. 87 Supplement Effective November 1, 2022 - Refer to Bulletin #147 for Benefit Status1462022-Oct-20Word PDF
Online version of NIDPF Vol. 87 effective October 1, 20221332022-Sep-29Word PDF
Delistings from NIDPF and NLPDP Benefit List Effective October 1, 20221292022-Sep-16Word PDF
NLPDP Benefit Status Effective October 1, 20221282022-Sep-15Word PDF
NIDPF Vol. 87 Supplement Effective October 1, 2022 - Refer to Bulletin #128 for Benefit Status1272022-Sep-15Word PDF
Online version of NIDPF Vol. 86 effective September 1, 20221242022-Sep-01Word PDF
NLPDP Benefit Status Effective September 1, 20221222022-Aug-25Word PDF
NIDPF Vol. 86 Supplement Effective September 1, 2022 - Refer to Bulletin #122 for Benefit Status1212022-Aug-25Word PDF
Online version of NIDPF Vol. 86 effective August 1, 20221122022-Jul-29Word PDF
NLPDP Benefit Status Effective August 1, 20221062022-Jul-22Word PDF
NIDPF Vol. 86 Supplement Effective August 1, 2022 - Refer to Bulletin #106 for Benefit Status1052022-Jul-22Word PDF
Online version of NIDPF Vol. 86 effective July 1, 2022922022-Jun-30Word PDF
NLPDP Benefit Status Effective July 1, 2022892022-Jun-28Word PDF
NIDPF Vol. 86 Supplement Effective July 1, 2022 - Refer to Bulletin #89 for Benefit Status882022-Jun-28Word PDF
Online version of NIDPF Vol. 86 effective June 1, 2022792022-Jun-01Word PDF
NLPDP Benefit Status Effective June 1, 2022752022-May-24Word PDF
Page  Go
Page 1 of 5
Document Name: Date Range: To


Document NameDateView
2022 - Payment Schedule2021-Dec-06Word PDF
2021 - Payment Schedule2020-Dec-17Word PDF
 
Page 1 of 1